Ginkgo Bioworks (DNA) - 2024 Q3 - Quarterly Results

Exhibit 99.1 https://files.reportify.cc/medi Ginkgo Bioworks Reports Third Quarter 2024 Financial Results Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs new and expanded deals with Novo Nordisk and achieves a major research milestone with Merck BOSTON, Mass – November 12, 2024 – Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programmin ...